No results for ‘’
Crestchem Ltd
₹134
(3.08%)
Sun, 13 Sept 2026, 00:02 am
Health Technology
Pharmaceuticals: Other
24.5KCrestchem PE Ratio
| Particulars | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 5.20 | 33.45 | 0 | 0 | 0 | 7.44 | 13.69 | 21.69 | 52.97 | 15.94 | 22.73 |
| Price to book ratio | 0 | 0 | 0 | 6.92 | 9.27 | 3.48 | 2.91 | 4.46 | 5.82 | 9.32 | 3.59 | 5.27 | 5.97 | 13.34 | 6.98 | 8.29 |
| Price to sales ratio | 0 | 0 | 0 | 34 | 9.05 | 33.53 | 78.66 | 26.62 | 72.26 | 42.39 | 0.53 | 1.03 | 1.55 | 2.20 | 1.62 | 2.48 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 44.85 | 18.87 | 0 | 0 | 0 | 5.31 | 0 | 9.93 | 14.10 | 57.58 | 31.32 |
| Enterprise value | 0 | 0 | 0 | 3.19Cr | 4.19Cr | 2.19Cr | 2.53Cr | 3.22Cr | 3.57Cr | 4.41Cr | 2.68Cr | 7.51Cr | 12.56Cr | 35.86Cr | 34.07Cr | 61.25Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 88.25 | 0 | 0 | 0 | 0 | 0 | 4.70 | 11.40 | 16.58 | 42.90 | 12.29 | 18.65 |
| Debt to equity ratio | 0.34 | 0.39 | 0.58 | 0.51 | 1.51 | 0.40 | 0.35 | 0.71 | 0.22 | 0.60 | 0.02 | 0.42 | 0.13 | 0 | 0 | 0 |
| Return on equity % | 0 | -17.58 | 8.38 | -16.87 | -6.17 | 92.53 | 8.94 | -17.61 | -26.13 | -30.33 | 63.73 | 47.63 | 31.94 | 28.82 | 56.09 | 44.06 |
Crestchem Ltd Price to Earnings Ratio
The Crestchem Ltd Price to Earnings Ratio is a key financial metric used by investors to evaluate Crestchem Ltd's valuation, profitability, and overall financial performance. Tracking the Crestchem Ltd Price to Earnings Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Crestchem Ltd (NSE: , BSE: 526269) is currently trading at ₹134, with a market capitalization of ₹39.52Cr. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Crestchem Ltd Price to Earnings Ratio is essential for fundamental analysis.
Crestchem Ltd Price to Earnings Ratio Current Value
The current Crestchem Ltd Price to Earnings Ratio stands at 22.73.
The latest Crestchem Ltd Price to Earnings Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Crestchem Ltd Price to Earnings Ratio Historical Trend
The Crestchem Ltd Price to Earnings Ratio has shown the following historical trend:
- 2024: 22.73
- 2023: 15.94
- 2022: 52.97
- 2021: 21.69
- 2020: 13.69
The recent rise in Crestchem Ltd Price to Earnings Ratio suggests strengthening valuation trends and improving market sentiment.
What Crestchem Ltd Price to Earnings Ratio Indicates for Investors
The Crestchem Ltd Price to Earnings Ratio plays a crucial role in understanding the company's financial health and valuation.
A higher P/E ratio indicates investors expect strong future earnings growth, while a lower ratio may signal undervaluation.
Crestchem Ltd Price to Earnings Ratio Analysis Summary
The Crestchem Ltd Price to Earnings Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Crestchem Ltd Price to Earnings Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Crestchem Ltd Price to Earnings Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.